PRMA Consulting
Smarter market access solutions

For pharmaceutical and biotechnology manufacturers, enabling faster patient access to therapies is a key challenge. An effective pricing, reimbursement, and market access strategy supported by unique digital applications helps solve the challenge.

PRMA Consulting - a ‘top 10’ Pharma Tech Outlook company and the go-to consulting partner for leading manufacturers - uses insight-based strategic consultancy and transformative digital applications to provide smarter market access solutions to pharmaceutical and biotechnology organizations around the world.

In this interview, Samara Ferguson, Senior Director, explains how manufacturers are benefitting from their partnerships with the consultancy.

For pharma manufacturers, what is it like to partner with PRMA Consulting?

“Before I joined PRMA Consulting, I worked for a global pharmaceutical manufacturer,” recalls Samara. “Our team had an asset with new indications that was in Phase 3. At the time, we had limited knowledge about the products already available in the landscape, the health technology assessment decisions, and the evidence packages.”

“We asked PRMA Consulting to guide us through our journey into a new market. Their team impressed me immediately. They really wanted to get to the root of our challenges and objectives. From understanding our complete requirements, PRMA Consulting was able to deliver creative recommendations, and we developed a scalable and sustainable market access strategy on time and on budget; we really reaped the benefits of that collaboration.”

“From my early experience, I found that the secret to truly successful market access is a tailored collaboration with the right people. Partnering with PRMA Consulting gives you access to a global, insight-based strategic consultancy that advances your market access strategy in new and unexpected ways.”

Today, Samara is a Senior Director at PRMA Consulting and partners with manufacturers to solve their most complex pricing, reimbursement, and market access challenges. Of special interest are the exciting benefits that digital solutions are providing in the US, European, and Asia-Pacific (APAC) markets.

US market access demands a deep understanding of payer and policy requirements

“Patient access to treatments is becoming more complex in the US. The biggest challenge is the vast number of unknowns as payers continue to shave budgets and pricing and prescription drug programs are overhauled. Our team in New York is often asked:

• How will ICER influence decisions made by payers and policymakers?

• Will there be drug pricing reforms at the legislative level?

• Will Medicare restructure and put more pressure on manufacturers and plan sponsors?

• How will biosimilar competition increase pressure on manufacturers?”

“Answering these questions requires a close pulse on the US systems by interacting with decision-makers and stakeholders at every level of the system. PRMA Consulting are at the forefront of this by engaging early with payers and policymakers using the award-winning PRMA Healthcheck^® digital application.”

The secret to truly successful market access is a tailored collaboration with the right people. Partnering with PRMA Consulting gives you access to a global, insight-based strategic consultancy that advances your market access in new and unexpected ways

APAC market access opportunities can be optimized with an expert, systematic approach

“The APAC market presents immense commercial opportunities for biopharma, medical device, and healthcare companies. While the region offers growth potential, the diversity of the markets poses challenges for market access.”

“The key to success is an up-to-date and in-depth understanding of the market access risks and opportunities across the region. But with APAC markets each having such distinct characteristics and priorities, some pharma organizations feel that their risk analysis and management is not as robust, data-driven, action-oriented, or far-reaching as the markets demand.”

“Developing the right evidence generation strategy requires insight into the key issues across all markets and collaboration to filter out which of these make sense in the local context. It isn’t easy, but PRMA Consulting can help you achieve it. Let’s say a manufacturer has a product in development, and their evidence generation plans need pressure testing. Our systematic PRMA Healthcheck^® process gives:

• a consistent framework for assessing evidence risk across markets

• informed, collaborative, and integrated decision-making

• an integrated evidence generation plan

• enhanced prioritization at the regional and/or market level.”

“Importantly for manufacturers, our trusted combination of digital applications and consulting expertise is proven and successful, which enables us to provide value to clients consistently. As one client said to us:

‘The PRMA Healthcheck^® has enabled us to evaluate commercial risk and opportunity throughout the development pathway. The value provided by this digital application takes us beyond market access and into commercialization.’”

What should manufacturers expect next from PRMA Consulting’s digital applications?

“Our mission is to enable faster patient access to therapies that improve health outcomes and we are achieving that every day. Through our expanding international team and secure digital applications, we will continue helping clients to answer the difficult questions, benefit from creative solutions, and have the flexibility they need to meet changing demands.”

PRMA Consulting, a ‘Top 10’ Pharma Tech Outlook company with a unique blend of insight based strategic consultancy and digital applications, is the perfect partner for pharma and biotech companies seeking smarter market access solutions.